These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 9188568)
1. In vivo dynamics of equine infectious anemia viruses emerging during febrile episodes: insertions/duplications at the principal neutralizing domain. Zheng YH; Sentsui H; Nakaya T; Kono Y; Ikuta K J Virol; 1997 Jul; 71(7):5031-9. PubMed ID: 9188568 [TBL] [Abstract][Full Text] [Related]
2. Insertions, duplications and substitutions in restricted gp90 regions of equine infectious anaemia virus during febrile episodes in an experimentally infected horse. Zheng YH; Nakaya T; Sentsui H; Kameoka M; Kishi M; Hagiwara K; Takahashi H; Kono Y; Ikuta K J Gen Virol; 1997 Apr; 78 ( Pt 4)():807-20. PubMed ID: 9129653 [TBL] [Abstract][Full Text] [Related]
3. Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony. Leroux C; Issel CJ; Montelaro RC J Virol; 1997 Dec; 71(12):9627-39. PubMed ID: 9371627 [TBL] [Abstract][Full Text] [Related]
4. Genetic variation of envelope gp90 gene of equine infectious anemia virus isolated from an experimentally infected horse. Pang H; Kong XG; Sentsui H; Kono Y; Sugiura T; Hasegawa A; Akashi H J Vet Med Sci; 1997 Dec; 59(12):1089-95. PubMed ID: 9450237 [TBL] [Abstract][Full Text] [Related]
5. Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype. Howe L; Leroux C; Issel CJ; Montelaro RC J Virol; 2002 Nov; 76(21):10588-97. PubMed ID: 12368301 [TBL] [Abstract][Full Text] [Related]
7. Amino acid mutations in the env gp90 protein that modify N-linked glycosylation of the Chinese EIAV vaccine strain enhance resistance to neutralizing antibodies. Han X; Zou J; Wang X; Guo W; Huo G; Shen R; Xiang W Viral Immunol; 2010 Oct; 23(5):531-9. PubMed ID: 20883167 [TBL] [Abstract][Full Text] [Related]
8. Unique evolution characteristics of the envelope protein of EIAV(LN₄₀), a virulent strain of equine infectious anemia virus. Wang X; Wang S; Lin Y; Jiang C; Ma J; Zhao L; Lv X; Wang F; Shen R; Zhou J Virus Genes; 2011 Apr; 42(2):220-8. PubMed ID: 21369830 [TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of the proviral DNA of equine infectious anemia virus in mules in Greece. Spyrou V; Papanastassopoulou M; Koumbati M; Nikolakaki SV; Koptopoulos G Virus Res; 2005 Jan; 107(1):63-72. PubMed ID: 15567035 [TBL] [Abstract][Full Text] [Related]
11. Replication ability in vitro and in vivo of equine infectious anemia virus avirulent Japanese strain. Zheng YH; Sentsui H; Sugita M; Nakaya T; Kishi M; Hagiwara K; Inoshima Y; Ishihara C; Kono Y; Lu JL; Ikuta K Virology; 2000 Jan; 266(1):129-39. PubMed ID: 10612667 [TBL] [Abstract][Full Text] [Related]
12. Genetic and biological variation in equine infectious anemia virus Rev correlates with variable stages of clinical disease in an experimentally infected pony. Belshan M; Baccam P; Oaks JL; Sponseller BA; Murphy SC; Cornette J; Carpenter S Virology; 2001 Jan; 279(1):185-200. PubMed ID: 11145901 [TBL] [Abstract][Full Text] [Related]
13. Enhanced sensitivity to neutralizing antibodies in a variant of equine infectious anemia virus is linked to amino acid substitutions in the surface unit envelope glycoprotein. Cook RF; Berger SL; Rushlow KE; McManus JM; Cook SJ; Harrold S; Raabe ML; Montelaro RC; Issel CJ J Virol; 1995 Mar; 69(3):1493-9. PubMed ID: 7853482 [TBL] [Abstract][Full Text] [Related]
14. Adaptive immunity is the primary force driving selection of equine infectious anemia virus envelope SU variants during acute infection. Mealey RH; Leib SR; Pownder SL; McGuire TC J Virol; 2004 Sep; 78(17):9295-305. PubMed ID: 15308724 [TBL] [Abstract][Full Text] [Related]
15. Deep sequencing and variant analysis of an Italian pathogenic field strain of equine infectious anaemia virus. Cappelli K; Cook RF; Stefanetti V; Passamonti F; Autorino GL; Scicluna MT; Coletti M; Verini Supplizi A; Capomaccio S Transbound Emerg Dis; 2017 Dec; 64(6):2104-2112. PubMed ID: 28299895 [TBL] [Abstract][Full Text] [Related]
16. Immune selection of equine infectious anemia virus env variants during the long-term inapparent stage of disease. Sponseller BA; Sparks WO; Wannemuehler Y; Li Y; Antons AK; Oaks JL; Carpenter S Virology; 2007 Jun; 363(1):156-65. PubMed ID: 17328936 [TBL] [Abstract][Full Text] [Related]
17. Development and characterization of an in vivo pathogenic molecular clone of equine infectious anemia virus. Cook RF; Leroux C; Cook SJ; Berger SL; Lichtenstein DL; Ghabrial NN; Montelaro RC; Issel CJ J Virol; 1998 Feb; 72(2):1383-93. PubMed ID: 9445039 [TBL] [Abstract][Full Text] [Related]
18. Transient immune suppression of inapparent carriers infected with a principal neutralizing domain-deficient equine infectious anaemia virus induces neutralizing antibodies and lowers steady-state virus replication. Craigo JK; Leroux C; Howe L; Steckbeck JD; Cook SJ; Issel CJ; Montelaro RC J Gen Virol; 2002 Jun; 83(Pt 6):1353-1359. PubMed ID: 12029150 [TBL] [Abstract][Full Text] [Related]
19. Genomic quasispecies associated with the initiation of infection and disease in ponies experimentally infected with equine infectious anemia virus. Lichtenstein DL; Issel CJ; Montelaro RC J Virol; 1996 Jun; 70(6):3346-54. PubMed ID: 8648664 [TBL] [Abstract][Full Text] [Related]